The present document has been conceived as the European update to the American
College of Cardiology (ACC)/American Heart Association (AHA)/ESC 2006 Guidelines for …

A unique and highly versatile technique, stress echocardiography (SE) is increasingly
recognized for its utility in the evaluation of non-ischaemic heart disease. SE allows for …

Introduction Several fluoroquinolone antibiotics have been associated with cardiac adverse
effects, leading to the withdrawal of some of these agents from the market. Cardiac side …

Introduction: Quinolones are among the most often prescribed antimicrobial agents. Some
types of toxicity observed during therapy with these drugs have gained much attention …

Tuberculosis (TB) remains a major public health problem, representing the second leading
cause of death from infectious diseases globally, despite being nearly 100% curable …

The FDA recently approved labeling changes advising against the use of azithromycin in
patients with known cardiovascular risk factors such as QT-interval prolongation …

Background: The association between oral fluoroquinolones (FQs) usage and risk of severe
arrhythmia-related events (ventricular arrhythmias and sudden cardiac death) remains …

Existing therapies for multi-drug resistant tuberculosis (MDR-TB) have substantial
limitations, in terms of their effectiveness, side-effect profile, and complexity of …

We performed a nationwide, population-based study for cardiovascular mortality among
users of macrolides, fluoroquinolones, and β-lactam/β-lactamase inhibitors in Taiwan …

Se recomienda a los profesionales de la salud que tengan en consideración la presente
guía de la ESC en la toma de decisiones clínicas en su ejercicio diario, así como en la …